HIV-1-infected patients with advanced disease failing a raltegravir-containing salvage regimen in São Paulo, Brazil-Reference-Cited by-同舟云学术

HIV-1-infected patients with advanced disease failing a raltegravir-containing salvage regimen in São Paulo, Brazil

Published:2014-03 Issue:3 Volume:43 Page:287-291
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

de Souza Cavalcanti Jaqueline,de Paula Ferreira Joao Leandro,Vidal Jose Ernesto,de Souza Guimarães Paula Morena,Moreira Denise Helena,de Macedo Brigido Luis Fernando

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Raltegravir with optimized background therapy for resistant HIV-1 infection;Steigbigel;N Engl J Med,2008

2. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial;Lennox;Lancet,2009

3. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks;Sax;Lancet,2012

4. In vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor;Kobayashi;Antimicrob Agents Chemother,2011

5. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase;Espeseth;Proc Natl Acad Sci U S A,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy;Drugs in Context;2024-05-16

2. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia;Journal of Antimicrobial Chemotherapy;2015-02-23

3. High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen;Journal of Antimicrobial Chemotherapy;2014-11-10